Trade Walgreen Boots Alliance - WBA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 0.11 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Walgreens Boots Alliance Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 17.54 |
Open* | 17.62 |
1-Year Change* | -50.42% |
Day's Range* | 17.57 - 18.2 |
52 wk Range | 19.68-37.96 |
Average Volume (10 days) | 21.62M |
Average Volume (3 months) | 278.02M |
Market Cap | 19.10B |
P/E Ratio | 33.32 |
Shares Outstanding | 862.38M |
Revenue | 142.41B |
EPS | 0.66 |
Dividend (Yield %) | 4.51467 |
Beta | 0.74 |
Next Earnings Date | Mar 26, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 19, 2024 | 18.20 | 0.72 | 4.12% | 17.48 | 18.22 | 17.48 |
Apr 18, 2024 | 17.54 | -0.04 | -0.23% | 17.58 | 17.67 | 17.46 |
Apr 17, 2024 | 17.57 | -0.15 | -0.85% | 17.72 | 17.80 | 17.48 |
Apr 16, 2024 | 17.59 | 0.00 | 0.00% | 17.59 | 17.77 | 17.48 |
Apr 15, 2024 | 17.60 | -0.28 | -1.57% | 17.88 | 18.11 | 17.48 |
Apr 12, 2024 | 17.80 | 0.02 | 0.11% | 17.78 | 17.92 | 17.65 |
Apr 11, 2024 | 18.04 | 0.03 | 0.17% | 18.01 | 18.12 | 17.70 |
Apr 10, 2024 | 17.98 | -0.68 | -3.64% | 18.66 | 18.71 | 17.81 |
Apr 9, 2024 | 19.13 | 0.00 | 0.00% | 19.13 | 19.32 | 19.01 |
Apr 8, 2024 | 19.12 | -0.02 | -0.10% | 19.14 | 19.42 | 18.98 |
Apr 5, 2024 | 19.07 | 0.33 | 1.76% | 18.74 | 19.18 | 18.57 |
Apr 4, 2024 | 18.94 | 0.41 | 2.21% | 18.53 | 19.02 | 18.46 |
Apr 3, 2024 | 18.43 | -0.19 | -1.02% | 18.62 | 19.11 | 18.43 |
Apr 2, 2024 | 18.65 | -0.84 | -4.31% | 19.49 | 19.56 | 18.61 |
Apr 1, 2024 | 19.48 | -2.09 | -9.69% | 21.57 | 21.68 | 19.45 |
Mar 28, 2024 | 21.62 | 0.81 | 3.89% | 20.81 | 21.98 | 20.58 |
Mar 27, 2024 | 20.95 | 0.31 | 1.50% | 20.64 | 21.03 | 20.51 |
Mar 26, 2024 | 20.47 | 0.28 | 1.39% | 20.19 | 20.58 | 20.18 |
Mar 25, 2024 | 20.58 | -0.04 | -0.19% | 20.62 | 21.00 | 20.51 |
Mar 22, 2024 | 20.52 | -0.33 | -1.58% | 20.85 | 20.99 | 20.52 |
Walgreen Boots Alliance Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, June 25, 2024 | ||
Time (UTC) 11:00 | Country US
| Event Q3 2024 Walgreens Boots Alliance Inc Earnings Release Q3 2024 Walgreens Boots Alliance Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total revenue | 139081 | 132703 | 132509 | 121982 | 120074 |
Revenue | 139081 | 132703 | 132509 | 121982 | 120074 |
Cost of Revenue, Total | 112049 | 104437 | 104442 | 95905 | 91915 |
Gross Profit | 27032 | 28266 | 28067 | 26077 | 28159 |
Total Operating Expense | 144142 | 130981 | 130291 | 121070 | 115308 |
Selling/General/Admin. Expenses, Total | 23872 | 24175 | 23636 | 21749 | 22048 |
Depreciation / Amortization | |||||
Interest Expense (Income) - Net Operating | -252 | -451 | 1156 | -302 | -164 |
Unusual Expense (Income) | 8472 | 2818 | 1057 | 3718 | 1509 |
Operating Income | -5061 | 1722 | 2218 | 912 | 4766 |
Interest Income (Expense), Net Non-Operating | -452 | 2173 | -499 | -602 | -495 |
Net Income Before Taxes | -5419 | 3985 | 1995 | 446 | 4359 |
Net Income After Taxes | -3561 | 4015 | 1328 | 107 | 3782 |
Minority Interest | 448 | 271 | 39 | 42 | 26 |
Equity In Affiliates | 33 | 50 | 627 | 31 | 8 |
Net Income Before Extra. Items | -3080 | 4336 | 1994 | 180 | 3816 |
Net Income | -3080 | 4336 | 2542 | 457 | 3982 |
Income Available to Common Excl. Extra. Items | -3080 | 4337 | 1994 | 179 | 3816 |
Income Available to Common Incl. Extra. Items | -3080 | 4337 | 2542 | 456 | 3982 |
Diluted Net Income | -3080 | 4337 | 2542 | 456 | 3982 |
Diluted Weighted Average Shares | 863.2 | 865.9 | 866.4 | 880.3 | 923.5 |
Diluted EPS Excluding Extraordinary Items | -3.56812 | 5.00866 | 2.30148 | 0.20334 | 4.13211 |
Dividends per Share - Common Stock Primary Issue | 1.92 | 1.91 | 1.87 | 1.83 | 1.76 |
Diluted Normalized EPS | 2.8114 | 7.12403 | 3.11358 | 3.0188 | 5.54981 |
Other, Net | 94 | 90 | 276 | 136 | 88 |
Total Extraordinary Items | 0 | 0 | 548 | 277 | 166 |
Other Operating Expenses, Total | 1 | 2 | 0 | ||
Total Adjustments to Net Income | 1 | -1 |
Aug 2023 | May 2023 | Feb 2023 | Nov 2022 | Aug 2022 | |
---|---|---|---|---|---|
Total revenue | 35422 | 35415 | 34862 | 33382 | 32449 |
Revenue | 35422 | 35415 | 34862 | 33382 | 32449 |
Cost of Revenue, Total | 28987 | 28826 | 27807 | 26429 | 26038 |
Gross Profit | 6435 | 6589 | 7055 | 6953 | 6411 |
Total Operating Expense | 35744 | 35713 | 34121 | 38564 | 33125 |
Selling/General/Admin. Expenses, Total | 6048 | 6091 | 6310 | 6286 | 7122 |
Depreciation / Amortization | |||||
Interest Expense (Income) - Net Operating | -65 | -58 | -75 | -53 | -88 |
Unusual Expense (Income) | 773 | 853 | 80 | 5903 | 52 |
Operating Income | -322 | -298 | 741 | -5182 | -676 |
Interest Income (Expense), Net Non-Operating | -77 | -123 | -141 | -110 | -111 |
Other, Net | 24 | 39 | 7 | 22 | 29 |
Net Income Before Taxes | -375 | -382 | 607 | -5270 | -758 |
Net Income After Taxes | -224 | -52 | 537 | -3823 | -523 |
Minority Interest | 28 | 166 | 159 | 94 | 85 |
Equity In Affiliates | 15 | 4 | 6 | 7 | 21 |
Net Income Before Extra. Items | -181 | 118 | 702 | -3722 | -417 |
Total Extraordinary Items | 0 | 0 | |||
Net Income | -181 | 118 | 702 | -3722 | -417 |
Total Adjustments to Net Income | 1 | 1 | 1 | 2 | |
Income Available to Common Excl. Extra. Items | -180 | 118 | 703 | -3721 | -415 |
Income Available to Common Incl. Extra. Items | -180 | 118 | 703 | -3721 | -415 |
Diluted Net Income | -180 | 118 | 703 | -3721 | -415 |
Diluted Weighted Average Shares | 863.5 | 863.8 | 863.4 | 863.6 | 864.5 |
Diluted EPS Excluding Extraordinary Items | -0.20845 | 0.13661 | 0.81422 | -4.30871 | -0.48005 |
Dividends per Share - Common Stock Primary Issue | 0.48 | 0.48 | 0.48 | 0.48 | 0.4775 |
Diluted Normalized EPS | 0.37342 | 0.77848 | 0.89619 | 0.13426 | -0.44095 |
Other Operating Expenses, Total | 1 | 1 | -1 | -1 | 1 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total Current Assets | 15503 | 16902 | 15814 | 18073 | 18700 |
Cash and Short Term Investments | 739 | 2472 | 1193 | 516 | 1023 |
Cash & Equivalents | 728 | 1358 | 1193 | 516 | 1023 |
Total Receivables, Net | 5381 | 5017 | 5663 | 7132 | 7226 |
Accounts Receivable - Trade, Net | 5381 | 5017 | 5663 | 7132 | 7226 |
Total Inventory | 8257 | 8353 | 8159 | 9451 | 9333 |
Other Current Assets, Total | 1126 | 1060 | 799 | 974 | 1118 |
Total Assets | 96628 | 90124 | 81285 | 87174 | 67598 |
Property/Plant/Equipment, Total - Net | 33254 | 32988 | 34140 | 35066 | 13478 |
Property/Plant/Equipment, Total - Gross | 46207 | 45831 | 47214 | 47521 | 24789 |
Accumulated Depreciation, Total | -12953 | -12843 | -13073 | -12456 | -11310 |
Goodwill, Net | 28187 | 22280 | 12421 | 15268 | 16560 |
Intangibles, Net | 13635 | 10730 | 9936 | 10753 | 10876 |
Long Term Investments | 3497 | 5495 | 6987 | 7338 | 6851 |
Other Long Term Assets, Total | 2552 | 1729 | 1987 | 676 | 1133 |
Total Current Liabilities | 24535 | 22583 | 22054 | 27070 | 25769 |
Accounts Payable | 12635 | 11255 | 11136 | 14458 | 14341 |
Accrued Expenses | 10716 | 10148 | 9482 | 8931 | 5468 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 1517 | 2400 |
Current Port. of LT Debt/Capital Leases | 974 | 1096 | 1342 | 2055 | 3338 |
Other Current Liabilities, Total | 210 | 84 | 94 | 109 | 222 |
Total Liabilities | 76608 | 64849 | 57866 | 66536 | 44087 |
Total Long Term Debt | 9064 | 11514 | 8649 | 13223 | 11098 |
Long Term Debt | 8145 | 10615 | 7675 | 12203 | 11098 |
Deferred Income Tax | 1318 | 1442 | 1850 | 1498 | 1785 |
Minority Interest | 8469 | 5133 | 721 | 498 | 641 |
Other Liabilities, Total | 33222 | 24177 | 24592 | 24247 | 4794 |
Total Equity | 20020 | 25275 | 23419 | 20638 | 23511 |
Common Stock | 12 | 12 | 12 | 12 | 12 |
Additional Paid-In Capital | 10661 | 10950 | 10988 | 10761 | 10639 |
Retained Earnings (Accumulated Deficit) | 33058 | 37801 | 35121 | 34210 | 35815 |
Treasury Stock - Common | -20717 | -20683 | -20593 | -20575 | -19057 |
Other Equity, Total | -2994 | -2806 | -2080 | -3760 | -3901 |
Total Liabilities & Shareholders’ Equity | 96628 | 90124 | 81285 | 87174 | 67598 |
Total Common Shares Outstanding | 863.674 | 864.639 | 865.374 | 865.604 | 895.388 |
Unrealized Gain (Loss) | 0 | 1 | -29 | -10 | 3 |
Capital Lease Obligations | 919 | 899 | 974 | 1020 | |
Short Term Investments | 11 | 1114 |
Aug 2023 | May 2023 | Feb 2023 | Nov 2022 | Aug 2022 | |
---|---|---|---|---|---|
Total Current Assets | 15503 | 16542 | 17689 | 19523 | 16902 |
Cash and Short Term Investments | 739 | 970 | 1840 | 4232 | 2472 |
Cash & Equivalents | 728 | 871 | 1088 | 2349 | 1358 |
Total Receivables, Net | 5381 | 5843 | 5730 | 4853 | 5017 |
Accounts Receivable - Trade, Net | 5381 | 5843 | 5730 | 4853 | 5017 |
Total Inventory | 8257 | 8164 | 8757 | 9322 | 8353 |
Other Current Assets, Total | 1126 | 1565 | 1362 | 1116 | 1060 |
Total Assets | 96628 | 98605 | 100479 | 92875 | 90124 |
Property/Plant/Equipment, Total - Net | 33254 | 33613 | 33600 | 32690 | 32988 |
Goodwill, Net | 28187 | 28371 | 28343 | 22582 | 22280 |
Intangibles, Net | 13635 | 13578 | 13864 | 10612 | 10730 |
Long Term Investments | 3497 | 3527 | 4069 | 4426 | 5495 |
Other Long Term Assets, Total | 2552 | 2974 | 2914 | 3042 | 1729 |
Total Current Liabilities | 24535 | 26170 | 28228 | 28036 | 22583 |
Accounts Payable | 12635 | 12029 | 12720 | 12184 | 11255 |
Accrued Expenses | 10716 | 10879 | 11109 | 11767 | 10148 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 974 | 3116 | 4275 | 3976 | 1096 |
Other Current Liabilities, Total | 210 | 146 | 124 | 109 | 84 |
Total Liabilities | 76608 | 77542 | 79287 | 72299 | 64849 |
Total Long Term Debt | 9064 | 9768 | 9751 | 8684 | 11514 |
Long Term Debt | 8145 | 8841 | 8820 | 7789 | 10615 |
Capital Lease Obligations | 919 | 927 | 931 | 895 | 899 |
Deferred Income Tax | 1318 | 1657 | 2081 | 1319 | 1442 |
Minority Interest | 8469 | 8456 | 8405 | 4163 | 5133 |
Other Liabilities, Total | 33222 | 31491 | 30822 | 30097 | 24177 |
Total Equity | 20020 | 21063 | 21192 | 20576 | 25275 |
Common Stock | 12 | 12 | 12 | 12 | 12 |
Additional Paid-In Capital | 10661 | 10667 | 10629 | 10477 | 10950 |
Retained Earnings (Accumulated Deficit) | 33058 | 33654 | 33952 | 33664 | 37801 |
Treasury Stock - Common | -20717 | -20731 | -20747 | -20762 | -20683 |
Unrealized Gain (Loss) | 0 | -150 | -162 | 1 | 1 |
Other Equity, Total | -2994 | -2389 | -2492 | -2816 | -2806 |
Total Liabilities & Shareholders’ Equity | 96628 | 98605 | 100479 | 92875 | 90124 |
Total Common Shares Outstanding | 863.674 | 863.261 | 862.796 | 862.342 | 864.639 |
Short Term Investments | 11 | 99 | 752 | 1883 | 1114 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 4065 | 2512 | 424 | 3962 | 5031 |
Cash From Operating Activities | 3898 | 5555 | 5485 | 5595 | 8263 |
Cash From Operating Activities | 1990 | 1973 | 1927 | 2038 | 1770 |
Deferred Taxes | -366 | 233 | -43 | 100 | -322 |
Non-Cash Items | -2285 | 409 | 2235 | 234 | -154 |
Cash Taxes Paid | 387 | 336 | 600 | 900 | 600 |
Cash Interest Paid | 420 | 916 | 584 | 676 | 577 |
Changes in Working Capital | 494 | 428 | 942 | -739 | 1938 |
Cash From Investing Activities | -1064 | 4072 | -1297 | -2307 | -5501 |
Capital Expenditures | -1734 | -1379 | -1374 | -1702 | -1367 |
Other Investing Cash Flow Items, Total | 670 | 5451 | 77 | -605 | -4134 |
Cash From Financing Activities | -1499 | -9036 | -4647 | -3047 | -5295 |
Financing Cash Flow Items | -1676 | -241 | -158 | 74 | -98 |
Total Cash Dividends Paid | -1659 | -1617 | -1747 | -1643 | -1739 |
Issuance (Retirement) of Stock, Net | -160 | -51 | -1534 | -3986 | -5054 |
Issuance (Retirement) of Debt, Net | 1996 | -7127 | -1208 | 2508 | 1596 |
Foreign Exchange Effects | -47 | -66 | -1 | -9 | 11 |
Net Change in Cash | 1288 | 525 | -460 | 232 | -2522 |
Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -3272 | -3816 | 4065 | 4566 | 4337 |
Cash From Operating Activities | 1238 | 493 | 3898 | 3812 | 2184 |
Cash From Operating Activities | 1055 | 495 | 1990 | 1502 | 1024 |
Deferred Taxes | -1600 | -1602 | -366 | -168 | 94 |
Non-Cash Items | -1737 | -937 | -2285 | -3052 | -2502 |
Cash Taxes Paid | 131 | 5 | 387 | 291 | 201 |
Cash Interest Paid | 288 | 160 | 420 | 336 | 211 |
Changes in Working Capital | 6792 | 6353 | 494 | 964 | -769 |
Cash From Investing Activities | -3583 | 1858 | -1064 | -1262 | -2181 |
Capital Expenditures | -1108 | -610 | -1734 | -1241 | -870 |
Other Investing Cash Flow Items, Total | -2475 | 2468 | 670 | -21 | -1311 |
Cash From Financing Activities | 1766 | -599 | -1499 | 753 | 769 |
Financing Cash Flow Items | 1409 | -68 | -1676 | -1948 | -2129 |
Total Cash Dividends Paid | -829 | -415 | -1659 | -1251 | -833 |
Issuance (Retirement) of Stock, Net | -128 | -144 | -160 | -174 | -155 |
Issuance (Retirement) of Debt, Net | 1314 | 28 | 1996 | 4126 | 3886 |
Foreign Exchange Effects | 13 | 4 | -47 | -33 | -16 |
Net Change in Cash | -566 | 1756 | 1288 | 3270 | 756 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Walgreen Company profile
What is Walgreen Boots Alliance?
Walgreen Boots Alliance is one of the largest pharmacy chains in the world. It is is split into three business segments: Retail Pharmacy Wholesale, Retail Pharmacy USA and Retail Pharmacy International. The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare. Among its health and beauty product brands are such household names as No7, Soap & Glory, Liz Earle and Botanics.
WBA also has one of the largest global pharmaceutical wholesale and distribution networks. The company is one of the world’s biggest purchasers of prescription drugs and many other health and wellbeing products. Walgreen Boots Alliance says its aim is to “help people across the world lead healthier and happier lives”.
Who are the key people at Walgreen Boots Alliance?
Stefano Pessina is Executive Vice Chairman and Chief Executive Officer of Walgreens Boots Alliance. The Italian-born billionaire’s career in the healthcare industry spans four decades. As Executive Deputy Chairman of Alliance UniChem, he led the company's landmark merger with Boots Group PLC in 2006. His voice carries a lot of weight in the sector.
WBA has two Co-Chief Operating Officers: Alex Gourlay and Ornella Barra. James A. Skinner serves as Executive Chairman.
What is the modern history of Walgreen Boots Alliance?
Walgreen Boots Alliance was established on December 31, 2014 after Walgreens, the US pharmacy store giant, purchased the 55% of Alliance Boots that it didn’t already own. Alliance Boots was a UK and Switzerland-based health and beauty group formed in 2006 through the merger of high street chain Boots and European pharmacy group Alliance UniChem.
What are the latest developments at Walgreen Boots Alliance?
It’s been a time of consolidation in the US healthcare industry, partly prompted by Amazon’s announcement that it is entering the sector to try to lower costs for patients. Some observers think Amazon could use its distribution expertise to undercut existing healthcare firms.
Walgreen Boots Alliance has been very active in pursuing potential deals. In September 2017, it agreed to buy 1,932 Rite Aid stores and three distribution centres for almost $4.4 billion in cash. WBA had previously sought to buy all of Rite Aid, but antitrust scrutiny scuppered the proposed deal.
In February 2018 it was reported that deal talks between Walgreens Boots Alliance and AmerisourceBergen about an acquisition of the wholesale drug distributor had ended without agreement. Walgreens already has a 26 per cent stake in Amerisource.
Since Walgreen Boots Alliance was founded at the end of 2014, the WBA share price has gone from $76 to a peak of $96 in July 2015 and back down to just $64 in October 2017. On 1 March 2018 the share price stood at $70.20, giving the company a market capitalisation of around $69.5 billion.
Our WBA chart tracks the ups and downs of the company’s share price over recent weeks and months.
Where does Walgreen Boots Alliance operate?
Walgreens Boots Alliance and the companies in which it has equity method investments have a presence in more than 25 countries around the world, with a total of over 13,000 stores. WBA also has one of the biggest global pharmaceutical wholesale and distribution networks, with over 390 distribution centres delivering to some 230,000 hospitals, health centres, pharmacies and doctors each year in over 20 countries. WBA is headquartered in Deerfield, Illinois.
Where is Walgreen Boots Alliance traded?
Walgreen is listed on the NASDAQ stock exchange. Check out Capital.com for the latest WBA chart.
Industry: | Drug Retailers (NEC) |
108 Wilmot Rd
DEERFIELD
ILLINOIS 60015
US
Income Statement
- Annual
- Quarterly
News
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com